Keyphrases
Denmark
100%
KRAS G12C
87%
Repeated Poisoning
87%
Poisoning
87%
Poison Control Centers
87%
Lung Cancer
87%
Regional Variability
87%
Overall Survival
87%
Precision Medicine
87%
Cancer Characteristics
87%
Temporal Trends
87%
Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC)
87%
Register Study
87%
Genetic Testing
87%
Treatment Patterns
87%
Danish National Patient Registry
80%
Cyclizine
62%
BRAF Testing
52%
Cancer Types
52%
Colorectal Cancer
52%
KRAS Testing
52%
KRAS mutation
39%
Quetiapine
37%
Regional Variation
35%
BRAF mutation
35%
Cancer Diagnosis
35%
Time to Next Treatment
32%
PD-L1 Expression
32%
Health Registries
28%
Psychiatric Comorbidity
25%
Paracetamol
25%
Anti-PD-1
21%
Patient Characteristics
21%
V-raf murine Sarcoma Viral Oncogene Homolog B1
17%
Optimal Testing
17%
All Cancer
17%
Cancer Treatment
17%
Nationwide Assessment
17%
Patient Self-testing
17%
Molecular Diagnostics
17%
Kirsten Rat Sarcoma Viral Oncogene Homolog
17%
Testing Approaches
17%
Melanoma Cancer
17%
Testing Rates
17%
Malignant Melanoma
17%
Poisoning Exposures
12%
Inclusion Criteria
12%
Number of Contacts
12%
Over-the-counter
12%
Toxic Substances
12%
Pharmacology, Toxicology and Pharmaceutical Science
Overall Survival
87%
Lung Cancer
87%
Non Small Cell Lung Cancer
87%
Malignant Neoplasm
87%
Toxic Injury
87%
Poison Control Centers
68%
Patient Registry
66%
Colorectal Cancer
52%
Cyclizine
48%
Sarcoma
35%
Melanoma
35%
Prevalence
29%
Quetiapine
29%
Paracetamol
19%
Comorbidity
19%
Drug
19%
Immunotherapy
14%
Epidermal Growth Factor Receptor
14%
Neoplasm
14%
Mood Disorder
9%
Personality Disorder
9%
Automutilation
9%
Cohort Study
9%
Toxic Substance
9%
Medicine and Dentistry
Overall Survival
87%
Personalized Medicine
87%
Lung Cancer
87%
Genetic Screening
87%
Non Small Cell Lung Cancer
87%
Cancer Types
65%
Programmed Death-Ligand 1
58%
Cancer Diagnosis
43%
Nodular Melanoma
43%
Sarcoma
43%
Colorectal Cancer
43%
Virus Oncogene
43%
Prevalence
29%
Patient Registry
21%
Cancer Therapy
21%
Immunotherapy
14%
Smoking
14%
Patient Characteristics
14%
Neoplasm
14%
Epidermal Growth Factor Receptor
14%